Robotic cancer surgery is an advanced form of minimally invasive surgery in which the surgeon controls specialised robotic instruments to perform selected cancer procedures through small incisions. The robotic system provides enhanced, magnified three-dimensional visualisation and precise instrument control while the surgeon remains in control of the operation.

Robotic surgery is not automatically better than open surgery for every patient. The appropriate surgical approach depends on the type and stage of cancer, tumour location, anatomy and the patient's overall health. In selected patients, robotic surgery may offer advantages such as smaller incisions, enhanced visualisation, precise instrument control and potentially less postoperative discomfort.

Robotic surgery may be considered for selected prostate, kidney, colorectal, rectal and gynaecological cancer procedures. Whether robotic surgery is appropriate depends on the cancer location, stage, tumour characteristics, anatomy and the patient's individual treatment plan.

No. The surgeon remains in control of the robotic system throughout the procedure. The robotic platform assists the surgeon by providing enhanced visualisation, controlled instrument movement and precise surgical manipulation. It does not independently perform the operation.

Recovery varies depending on the type and extent of surgery, the cancer being treated and the patient's overall health. Minimally invasive techniques may help reduce surgical trauma and postoperative discomfort in appropriately selected patients. Your surgeon can explain the expected recovery period based on your specific procedure.

Suitability is determined after evaluating the cancer type, stage, imaging, pathology, tumour location, anatomy and overall health. A surgical oncologist can review these factors and explain whether robotic surgery is an appropriate option for your individual treatment plan.